{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/fda/warning-letters/check?name=Novo%20Nordisk%20Inc.","name":"Novo Nordisk Inc.","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters","generated_at":"2026-10-06T09:51:42.965Z"},"count":2,"matches":[{"id":"c1f71dde3caf0be1","posted_date":"2026-03-10","letter_issue_date":"2026-03-05","company_name":"Novo Nordisk Inc.","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"Postmarketing Adverse Drug Experience Reporting Requirements","canonical_url":"https://api.morvs.ai/fda-warning/c1f71dde3caf0be1"},{"id":"ac9815703c6587ce","posted_date":"2025-09-16","letter_issue_date":"2025-09-09","company_name":"Novo Nordisk Inc.","issuing_office":"Center for Drug Evaluation and Research (CDER)","subject":"False & Misleading Claims/Misbranded","canonical_url":"https://api.morvs.ai/fda-warning/ac9815703c6587ce"}]}